Biomarkers to guide therapy or surveillance for prostate cancer

Author： Citrin Deborah   Hudak Kathryn   Camphausen Kevin A  

Publisher： Future Medicine

ISSN： 1752-0363

Source： Biomarkers in Medicine, Vol.7, Iss.6, 2013-12, pp. : 827-829

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?

By  

Urologia Internationalis, Vol. 95, Iss. 2, 2015-03 ,pp. : 125-131

Karger

Access to resources Recommend Favorite

Applying precision medicine to the active surveillance of prostate cancer

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3403-3411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combining biomarkers to detect disease with application to prostate cancer

By Etzioni* R.   Kooperberg C.   Pepe M.   Smith R.   Gann P.H.  

Biostatistics, Vol. 4, Iss. 4, 2003-10 ,pp. : 523-538

Oxford University Press

Access to resources Recommend Favorite

Circulating nucleic acids as biomarkers of prostate cancer

By Sita-Lumsden Ailsa   Fletcher Claire E   Dart D Alwyn   Brooke Greg N   Waxman Jonathan   Bevan Charlotte L  

Biomarkers in Medicine, Vol. 7, Iss. 6, 2013-12 ,pp. : 867-877

Future Medicine

Access to resources Recommend Favorite

The Evolving Role of Biomarkers in Personalized Lung Cancer Therapy

By  

Respiration, Vol. 93, Iss. 1, 2016-11 ,pp. : 1-14

Karger

Access to resources Recommend Favorite